Systemic mast cell disease: Analysis of 58 cases and literature review

Medicine (United States)

Volumn 67, Issue 6, 1988, Pages 345-368

  Travis, William D ^a   Li, Chin Yang ^a   Bergstralh, Erik J ^b   Yam, Lung T ^c,d   Swee, Ronald G ^b  

^a Division of Laboratory Medicine and Pathology   (United States)

^b Department of Health Sciences Research ^*  (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLASSIFICATION; FATALITY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL DISEASE; MAST CELL LEUKEMIA; PRIORITY JOURNAL; REVIEW; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

FEMALE; HUMAN; MALE; MASTOCYTOSIS; MIDDLE AGE; MODELS, STATISTICAL; PROGNOSIS; STATISTICS;

EID: 0024271215     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-198811000-00001     Document Type: Article

References (329)

1. Abdel-Aal H, Boseils AW, Bayomy WK Salem SZ. Quantitative and qualitative changes in mast cells in the skin of normal Egyptians. Acta Derm Venerol (Stockh) 56: 435-439, 1976.
2. Achord JL, Langford H. The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis. Am J Med 69: 610-614, 1980.
3. Aiba M, Iri H, Suzuki H, Kageyama K, Kawai T, Abe O, Murai M, Tazake H, Saruta T. Numerous mast cells in an 11-deoxycorticosterone-producing adrenocortical tumor. Arch Pathol Lab Med 109: 357-360, 1985.
4. Ammann RW, Vetter D, Deyhle P, Tschen H Sulser H, Schmid M. Gastrointestinal involvement in systemic mastocytosis. Gut 17: 107-112, 1976.
5. Asboe-Hansen G, Kaalund-Jørgensen O. Systemic mast cell disease involving skin, liver, bone marrow, and blood associated with disseminated xanthomata. Acta Haematol 16: 273-279, 1956.
6. Asboe-Hansen G, Levi H, Nielsen A, Bentzon MW: Premitotic uptake of tritiated thymidine by mast cells. Acta Pathol Microbiol Scand 63: 533-548, 1965.
7. Balbi E. Ricerche intorno alla patogenesi dell'urticaria pigmentosa. G Ital Dermatol 90: 82-100, 1949.
8. Bank S, Marks IN. Malabsorption in systemic mast cell disease. Gastroenterology 45: 535-549, 1963.
9. Barer M, Peterson LFA, Dahlin DC, Winkelmann RK, Stewart JR. Mastocytosis with osseous lesions resembling metastatic malignant lesions in bone. J Bone Joint Surg 50A: 142-152, 1968.
10. Barr RD, Kendall AG. Acute leukemia with mastocytosis. East Afr Med J 49: 226-229, 1972.
11. Bates EO. A quantitative study and interpretation of the occurrence of basophile (mast) cells in the subcutaneous tissue of the albino rat. Anat Rec 61: 231-238, 1935.
12. Beaven MA. Histamine: Its role in physiological and pathological processes. Monographs in Allergy 13: 1-113, 1978.
13. Belcon MC, Collins SM, Castelli MF, Qizilbash AH. Gastrointestinal hemorrhage in mastocytosis. Can Med Assoc J 122: 311-314, 1980.
14. Bennett JM, Catovsky D, Daniel M T, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. The French-American-British Cooperative Group. Br J Haematol 51: 189-199, 1982.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A Report of the French-American-British Cooperative Group. Ann Intern Med 103: 620-625, 1985.
16. Bennett JM, Catovsky D, Daniel M T, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 103: 460-462, 1985.
17. Bensley JH. On the origin of mast cells. Anat Res 112: 310, 1952.
18. Berlin C. Urticaria pigmentosa as a systemic disease. Arch Dermatol 71: 703-712, 1955.
19. Berke M, Walker PC. Generalized mastocytosis. Fatal case with autopsy åndings. Calif Med 106: 468-472, 1967.
20. Berman BA, Ross RN. Systemic mastocytosis. Cutis 29: 544-555, 1982.
21. Bienenstock J, Befus AD, Pearce F, Denburg J, Goodacre R. Mast cell heterogeneity: Derivation and function, with emphasis on the intestine. J Allergy Clin Immunol 70: 407-412, 1982.
22. Bigelow EL. Changing concepts concerning mastocytosis. J Pediatrics 58: 499-507, 1961.
23. Bloom G, Franzen S, Sirén M. Malignant systemic mast cell disease (mastocytoma) in man. Acta Medica Scand 168: 95-102, 1960.
24. Bonnet P, Smadja C, Szekely A M, Delage Y, Calmus Y, Poupon R, Franco D. Intractable ascites in systemic mastocytosis treated by portal diversion. Dig Dis Sci 32: 209-213, 1987.
25. Bowdler AJ, Tullett GL. Urticaria pigmentosa and polycythaemia vera, a case report. Br Med J I: 396-397, 1960.
26. Boxer M, Greenberger PA, Patterson R. Clinical summary and course of idiopathic anaphylaxis in 73 patients. Arch Intern Med 147: 269-272, 1987.
27. Braverman DZ, Dollberg L, Shiner M. Clinical, histological, and electron microscopic study of mast cell disease of the small bowel. Am J Gastroenterol 80: 30-37, 1985.
28. Bredfeldt JE, O'Laughlin JC, Durham JB, Blessing LD. Malabsorption and gastric hyperacidity in systemic mastocytosis. Results of cimetidine therapy. Am J Geistroenterol 74: 133-137, 1980.
29. Brink AJ, Marshall J. Mastocytosis (Urticaria pigmentosa) and polycythaemia rubra vera. S Afr Med J 37: 1307-1308, 1963.
30. Brodeur P, Gardner LI. Urticaria pigmentosa as a problem in diagnosis. Report of two cases, one with systemic involvement. N Engl J Med 254: 1165-1168, 1956.
31. Brogren N, Duner H, Hamrin B, Pemow B, Theander G, Waldenstrom J. Urticaria pigmentosa (mastocytosis). A study of nine cases with special reference to the excretion of histamine in urine. Acta Med Scand 163: 223-233, 1959.
32. Broitman SA, McCray RS, May JC, Deren JJ, Ackroyd F, Gottlieb LS, McDermott W, Zamcheck N. Mastocytosis and intestinal malabsorption. Am J Med 48: 382-89, 1970.
33. Browarsky IL, Lotz MJ. Systemic mast cell disease. S Med J 76: 508-511, 1983.
34. Brunning RD, McKenna RW, Rosai J, Parkin JL, Risdall R. Systemic mastocytosis, extracutaneous manifestations. Am J Surg Pathol 7: 425-438, 1983.
35. Buckley JD. Additive and multiplicative models for relative survival rates. Biometrics 40: 51-62, 1984.
36. Bureau Y, Rodat G, Barriere H, Litoux P, Bureau B. Mastocytose cutanee de l'adulte avec mastocytose hipatique, et monocytose sanguine. Societe de Dermatologie et de Syphiligraphie 72: 850-853, 1965.
37. Biirgel E, Oleck HG. Skelettveranderungen bei der Urticaria pigmentosa. Fortschr Rontgenstr 90: 185-190, 1959.
38. Burklow SL, Marney SR. Mastocytosis: One-year experience. South Med J 80: 51-54, 1987.
39. Businco L, Cantani A, Businco E, Pepys J. Systemic mastocytosis in a 5-year-old child: Successful treatment with disodium cromoglycate. Clin Allergy 14: 147-152, 1984.
40. Bussolati G, Gugliotta P. Nonspecific staining of mast cells by avidin-biotin-peroxidase complexes (ABC). J Histochem Cytochem 31: 1419-1421, 1983.
41. Butterfield JH, Weiler DW, Dewald G, Gleich GJ. Autonomously growing human mast cell leukemia line (abstract). Fed Proc 45: 736, 1986.
42. Cains LJ. Systemic mastocytosis. Australas J Dermatol 13: 111-113, 1972.
43. Campbell EW, Hector D, Gossain V. Heparin activity in systemic mastocytosis. Ann Intern Med 90: 940-941, 1979.
44. Caplan RM. The natural course of urticaria pigmentosa. Arch Derm 87: 146-157, 1963.
45. Capron J-P, Lebrec D, Degott C, Chivrac D, Coevoet B, Delobel J. Portal hypertension in systemic mastocytosis. Gastroenterol 74: 595-597, 1978.
46. Carter D, Eggleston JC. Tumors of the lower respiratory tract. Atlas of Tumor Pathology, Second Series, Fascicle 17, pp 300-307, 1980.
47. Case Records of the Massachusetts General Hospital. Case 38-1986. N Engl J Med 315: 816-824, 1986.
48. Charrette EE, Mariano AV, Laforet EG. Solitary mast cell "tumor" of lung, its place in the spectrum of mast cell disease. Arch Intern Med 118: 358-362, 1966.
49. Chemer JA, Jensen RT, O'Dorisio TM, Gardner JD, Metcalfe DD. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology 95: 657-667, 1988.
50. Claman HN. New hope for neurofibromatosis? The mast cell connection. JAMA 258: 823, 1987.
51. Clancy RL Gauldie J, Vallieres M, Bienenstock J, Day RP, Pineo GF. An approach to immunotherapy using antibody to IgE in mast cell leukemia. Cancer 37: 693-696, 1976.
52. Clemett AR, Fishbone G, Levine RJ, James AE, Janower M. Gastrointestinal lesions in mastocytosis. Am J Roentgenol 103: 405-412, 1968.
53. Clinical Pathologic Conference: Systemic mastocytosis. Am J Med 61: 671-679, 1976.
54. Clinicopathologic conference: Osteopenia. Am J Med 69: 915-922, 1980.
55. Cohen AH, Vogel JM. Systemic mastocytosis and multiple carcinomas. Mt Sinai J Med 39: 365-370, 1972.
56. Cohen HJ, Raisbeck MJ, Baer RL. Acquired (adult) urticaria pigmentosa. Disappearance after removal of intestinal carcinoma. Dermatologica 121: 386-389, 1960.
57. Cooper AJ, Winkelmann RK, Wiltsie JC. Hematologic malignancies occurring in patients with urticaria pigmentosa. J Am Acad Dermatol 7: 215-220, 1982.
58. Coser P, Quaglino D, de Pasquale A, Colombetti V, Prinoth O. Cytobiological and clinical aspects of tissue mast cell leukemia. Br J Haematol 45: 5-12, 1980.
59. Cowen T, Trigg P, Eady RAJ. Distribution of mast cells in human dermis: Development of a mapping technique. Br J Dermatol 100: 635-640, 1979.
60. Cox DR. Regression models and life-tables (with discussion). J R Statist Soc 34 (Series B): 187-220, 1972.
61. Craig SS, DeBlois G, Schwartz LB. Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase. Am J Pathol 124: 427-435, 1986.
62. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM. Articular mastocytosis in rheumatoid arthritis. Arthritis and Rheumatism 27: 845-851, 1984.
63. Czametzki BM, Behrendt H. Urticaria pigmentosa: Clinical picture and responses to oral sodium cromoglycate. Br J Dermatol 105: 563-567, 1981.
64. Czametzki BM, Sterry W, Bazin H, Kalveram KJ. Evidence that tissue mast cells derive from mononuclear phagocytes. Int Arch Allergy Appl Immunol 67: 44-48, 1982.
65. Czametzki BM, Kruger G, Sterry W. In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol 71: 161-167, 1983.
66. Dale DC, Guerry D, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine 58: 128-144, 1979.
67. Dalton R, Chan L, Batten E, Eridani S. Mast cell leukaemia: evidence for bone marrow origin of the pathological clone. Br J Haematol 64: 397-406, 1986.
68. Daniel M-T, Flandrin G, Bernard J. Leucemie aigue à mastocytes: etude cytochimique et ultras truet urale, a propos d'une observation. Nouv Rev Fr Hematol 15: 319-332, 1975.
69. Dantzig PI. Tetany, malabsorption, and mastocytosis. Arch Intern Med 135: 1514-1518, 1975.
70. Davidson S, Mansour A, Gallily R, Smolarski M, Rofolovitch M, Ginsburg H. Mast cell differentiation depends on T cells and granule synthesis on fibroblasts. Immunology 48: 439-452, 1983.
71. Debray C, Leymarios J, Cerf M, Boequet L, Marche C, Boivin P, Kahn A, Husson JM. Mastoeytose digestive. Presentation d'un cas et revue de la Iitterature. Arch Fr MaI App Dig 62: 411-417, 1973.
72. Demis DJ, Walton MD, Higdon RS. Histaminuria in urticaria pigmentosa. Arch Dermatol 83: 127-138, 1961.
73. Demis DJ. The mastocytosis syndrome: Clinical and biological studies. Ann Intern Med 59: 194-206, 1963.
74. Demis DJ. Mast cell diseases (urticaria pigmentosa). In: Demis DJ, Dobson RL, McGuire J, eds. Clinical Dermatology. 10th ed. Philadelphia: Harper and Row, Unit 4-11, pp. 1-27, 1983.
75. Denburg JA, Richardson M, Telizyn S, Bienenstock J. Basophilmast cell precursors in human peripheral blood. Blood 61: 775-780, 1983.
76. Denburg JA, Telizyn S, Ahlstedt S, Olafsson JH, Roupe G, Bienenstock J. Basophil/mast cell precursors in mast cell proliferative disorders. Clin Invest Med 9: 21-25, 1986.
77. Dewald GW, Broderick DJ, Tom WW, Hagstrom JE, Pierre RV. The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cyogenet 18: 1-10, 1985.
78. Diamond JH, Gross L. Urticaria pigmentosa complicated by polycythemia vera. Blood 27: 253-257, 1966.
79. Diez Martin JL, Li C-Y, Banks PM. Blastic variant of hairy cell leukemia. Am J Clin Pathol 87: 576-583, 1987.
80. Dodd NJ, Bond MG. Fatal anaphylaxis in systemic mastocytosis. J Clin Pathol 32: 31-34, 1979.
81. Dollberg L, Gurevitz M, Freier S. Gastrointestinal mast cells in health, and in coeliac disease and other conditions. Arch Dis Child 55: 702-705, 1980.
82. Dolovich J, Punthgikee ND, MacMillan AB, Osbaldeston GJ. Systemic mastocytosis: Control of lifelong diarrhea by ingested disodium cromoglycate. Can Med Assoc J 111: 684-685, 1974.
83. Downey H. Die Entstehung von Mastzellen aus Lymphocyten und Plasmazellen. Verh Anat Gesellsch 25: 74-80, 1911.
84. Dvorak AM. Mast-cell hyperplasia and degranulation in Crohn's disease. In: Papys J, Edwards AM, eds. The Mast Cell, Its Role in Health and Diseases. Bath, England: Pitman Press, pp 657-662, 1979.
85. Dvorak AM. Mast-cell degranulation in human hearts Getter to editor). N Engl J Med 315: 969-970, 1986.
86. Dvorak HF, Dvorak AM, Simpson AM, Richerson HM, Leskowitz S, Kamovsky MJ. Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. J Exp Med 132: 558-582, 1970.
87. Dvorak HF, Mihm MC, Dvorak AM. Morphology of delayed-type hypersensitivity reactions in man. J Invest Dermatol 67: 391-401, 1976.
88. Eady RAJ. The mast cells: Distribution and morphology. Clin Exp Dermatol I: 313-321, 1976.
89. Eady RAJ, Cowen T, Marshall TF, Plummer V, Greaves MW. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 100: 623-633, 1979.
90. Eagan JW, Baughman KL, Miller S, Conley CL, Eggleston JC. Systemic mastocytosis in a patient with polycythemia vera treated with radioactive phosphorus. Blood 49: 563-571, 1977.
91. Efrati P, Klajman A, Spitz H. Mast cell leukemia?-malignant mastocytosis with leukemia-like manifestations. Blood 12: 869-882, 1957.
92. Ehrlich P. Beitrage zur Kenntniss der Anilinfarbungen und ihrer Verwendung in der mikroskopischen Technik. Arch Mikrosk Anat 13: 263-277, 1877.
93. Ehrlich P. Beiträge zur Kenntniss der granulirten Bindegewebszellen und der eosinophilen Leukocythen. Arch Anat Physiol 3: 166-169, 1879.
94. Ellis JM. Urticaria pigmentosa. A report of a case with autopsy. Arch Pathol 48: 426-435, 1949.
95. Ende N, Chemiss NI. Splenic mastocytosis. Blood 12: 631-641, 1958.
96. Enerback L. Mast cells in rat gastrointestinal mucosa. I. Effects of fixation. Acta Pathol Microbiol Scand 66: 289-302, 1966.
97. Enerbaek L. The gut mucosal mast cell. Monographs in Allergy 17: 222-232, 1981.
98. Ensslen RD, Jackson FI, Reid AM. Bone and gallium scans in mastocytosis: Correlation with count rates, radiography, and microscopy. J Nucl Med 24: 586-588, 1983.
99. Estensen RD. What is the role of myocardial mast cells? Hum Pathol 17: 536-538, 1985.
100. Fallon MD, Whyte MP, Teitelbaum SL. Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients. Hum Pathol 12: 813-820, 1981.
101. Fawcett DW. An experimental study of mast cell degranulation and regeneration. Anat Rec 121: 29-51, 1955.
102. Feldman EJ, Isenberg JI. Effects of metiamide on gastric acid hypersecretion, steatorrhea and bone marrow function in a patient with systemic mastocytosis. N Engl J Med 295: 1178-1179, 1976.
103. Femex M. The Mast-Cell System. Its Relationship to Atherosclerosis, Fibrosis and Eosinophils. Baltimore: Williams & Wilkins, 1968.
104. Fishman RS, Fleming CR, Li C-Y. Systemic mastocytosis with review of gastrointestinal manifestations. Mayo Clin Proc 54: 51-54, 1979.
105. Fohlmeister I, Reber T, Fischer R. Bone marrow mast cell reaction in preleukaemic myelodysplasia and in aplastic anaemia. Virchows Arch [Pathol Anat] 405: 503-509, 1985.
106. Forni M, Klatt EC, Shaw ST, Taylor CR, Lukes RJ, Meyer PR. Immunohistochemical characterization of reactive and neoplastic mast cells. Am J Clin Pathol 80: 660-665, 1983.
107. Fouear E, Piette WW, Tse DT, Goeken J, Olmstead AD. Urtieating histiocytosis: A mast cell-rich variant of histiocytosis X. J Am Acad Dermatol 14: 867-873, 1986.
108. Fowler JF, Parsley WM, Cotter PG. Familial urticaria pigmentosa. Arch Dermatol 122: 80-81, 1986.
109. Frame B, Nixon RK. Bone marrow mast cells in osteoporosis of aging. N Engl J Med 279: 626-630, 1968.
110. Friedman BI, Will JJ, Freiman DG, Braunstein H. Tissue mast cell leukemia. Blood 13: 70-78, 1958.
111. Frieri M, Papadopoulos NM, Kaliner MA, Metcalfe DD. An abnormal pre-ß lipoprotein in patients with systemic mastocytosis. Ann Intern Med 97: 220-221, 1982.
112. Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis, results of a double-blind clinical trial. Am J Med 78: 9-14, 1985.
113. Gabriel LC, Escribano LM, Marie J-P, Zittoun R, Navarro JL. Peroxidase activity in circulating mast cells in blast crisis of chronic granulocytic leukemia. Comparative studies with basophils and cutaneous mast cells. Am J Clin Pathol 86: 212-219, 1986.
114. Galli SJ. New approaches for the analysis of mast cell maturation, heterogeneity, and function. Fed Proc 46: 1906-1914, 1987.
115. Garriga MM, Friedman MM, Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 1988, in press.
116. Ghandur-Mnaymneh L, Gould E. Systemic mastocytosis with portal hypertension. Autopsy findings and ultrastructural study of the liver. Arch Pathol Lab Med 109: 76-78, 1985.
117. Goldgräber MB: Steatorrhea a clinical-pathologic correlation. Isr Med J 22: 156-175, 1963.
118. Goldhaber P. Heparin enhancement of factors stimulating bone resorption in tissue culture. Science 147: 407-408, 1978.
119. Gonnella JS, Lipsey AI. Mastocytosis manifested by hepatosplenomegaly. Report of a case. N Engl J Med 271: 533-535, 1964.
120. Granerus G, Roupe G. Increased urinary methylimidazoleacetic acid (MeImAA) as an indicator of systemic mastocytosis. Agents and Actions 12: 29-31, 1982.
121. Granerus G, Olafsson JH, Roupe G. Studies on histamine metabolism in mastocytosis. J Invest Dermatol 80: 410-416, 1983.
122. Granerus G, Wass U. Urinary excretion of histamine, methyl-histamine (I-MeHi) and methylimidazoleacetic acid (MeImAA) in mastocytosis: Comparison of new HPLC methods with other present methods. Agents and Actions 14: 341-345, 1984.
123. Greaves MW, Phillips CB. Mast cell in disease and its pharmacologic regulation. J Invest Dermatol 71: 92-94, 1978.
124. Green RM, Cordero A, Winkelmann RK. Epidermal mast cells. Arch Dermatol 113: 166-169, 1977.
125. Griffith GC, Nichols G, Asher JD, Flanagan B. Heparin osteoporosis. JAMA 193: 91-94, 1965.
126. Griffiths WAD, Daneshbod K. Pseudoxanthomatous mastocytosis. Br J Dermatol 93: 91-95, 1975.
127. Grundfest S, Cooperman AM, Ferguson R, Benjamin S. Portal hypertension associated with systemic mastocytosis and splenomegaly. Gastroenterol 78: 370-373, 1980.
128. Grussendorf E-I, Biir T, Behrendt H, Redemann M. Beitrag zur diffusen kutanen Mastozytose im Kindesalter. Dermatologica 157: 1-12, 1978.
129. Gupta SM, Gupta A Spencer RP, Herrera NE. Bone and spleen lesions in systemic mastocytosis. Clin Nucl Med 8: 34, 1983.
130. Guy-Grand D, Griscelli C, Vassalli P. The mouse gut T-lymphocyte, a novel type of T-cell. J Exp Med 148: 1661-1677, 1978.
131. Hancock BW, Dandona P, Cumberland DC, Jarratt JA. Systemic mastocytosis-central nervous system features and lymphographic demonstration of lymph node involvement. Postgrad Med J 52: 659-662, 1976.
132. Handler G, Isenberg L, Greaves MW. Concurrence of urticaria pigmentosa and polycythaemia rubra vera. Clin Exp Dermatol 6: 43-46, 1981.
133. Hatamochi A, Fujiwara K, Ueki H. Effects of histamine on collagen synthesis by cultured fibroblasts from guinea pig skin. Arch Dermatol Res 277: 60-64, 1985.
134. Hatanaka K, Kitamura Y, Nishimune Y. Local development of mast cells from bone marrow-derived precursors in the skin of mice. Blood 53: 142-147, 1979.
135. Havard CWH, Scott RB. Urticaria pigmentosa with visceral and skeletal lesions. Q J Med 28: 459-470, 1959.
136. Hellstrbm B, Holmgren HJ. Numerical distribution of mast cells in the human skin and heart. Acta Anat 10: 81-107, 1950.
137. Hills E, Dunstan CR, Evans RA. Bone metabolism in systemic mastocytosis. J Bone Joint Surg 63A: 665-669, 1981.
138. Hirschowitz BI, Groarke JF. Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 90: 769-771, 1979.
139. Hirson C. Urticaria pigmentosa with disseminated mastocytosis controlled with chlorambucil. Proc R Soc Med 58: 697, 1965.
140. Horny H-P, Parwaresch MR, Lennert K. Basophilic leukemia and generalized mastocytosis. Verh Dtsch Ges Path 67: 192-197, 1983.
141. Horny H-P, Parwaresch MR, Lennert K. Klinisches Bild und Prognose generalisierter Mastozytoeen. Klin Wochenschr 61: 785-793, 1983.
142. Horny H-P, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 16: 808-814, 1985.
143. Homy H P, Parwaresch MR, Kaiserling E, Müller K, Olbermann M, Mainzer K, Lennert K. Mast cell sarcoma of the larynx. J Clin Pathol 39: 596-602, 1986.
144. Horton MA, O'Brien HAW. Characterization of human mast cells in long-term culture. Blood 62: 1251-1260, 1983.
145. Hutton SW, Morley JE, Parent MK, Johnson GJ, Silvis SE. Thyrotropin-releasing hormone suppressed gastric acid output in patients with Zollinger-Ellison syndrome and systemic mastocytosis. Am J Med 71: 957-960, 1981.
146. Ishizaka T, Okudaira H, Mauser LE, Ishizaka K. Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cells. J Immunol 116: 747-754, 1976.
147. Ishizaka T. Membreine events in the triggering of mast cells. In: Pepys J, Edwards AM, eds. The Mast Cell, Its Role in Health and Diseeise. Bath, England: Pitman Press, pp. 21-29, 1979.
148. Ives DR, Thompson DM. Urticaria pigmentosa with spinal osteoporosis. Proc Roy Soc Med 66: 175-176, 1973.
149. Jeimes MP, Eady RAJ. Familial urticaria pigmentosa with giant mast cell granules. A clinical, light, and electron microscopic study. Arch Dermatol 117: 713-718, 1981.
150. Janower ML. Mastocytosis of the gastrointestinal tract. Report of a case. Acta Radiologica (Stockh) 57: 489-493, 1962.
151. Jamum S, Zachariae H. Meistocytosis (urticaria pigmentosa) of skin, stomach eind gut with malabsorption. Gut 8: 64-68, 1967.
152. Jarrett EEE, Haig DM. Mucosal mast cells in vivo and in vitro. Immunology Today 5: 115-118, 1984.
153. Jeanselme E, Touraine A. Urticaire pigmentaire avec hypertrophie du foie et splénomlgalie, hematologie, radiotherapie. Bull Soc Frane Derm Syph 26: 98-101, 1919.
154. Johnson GJ, Silvis SE, Roitman B, Blumenthal M, Gilbert HS. Long-term treatment of systemic mastocytosis with histamine H, receptor antagonists. Am J Gastroenterol 74: 485-489, 1980.
155. Johnson WC, Helwig EB. Solitary mastocytosis (urticaria pigmentosa). Arch Dermatol 84: 806-815, 1961.
156. Jordon HE. On the nature of the basophilic granulocytes of the blood and tissues. Anat Rec 33: 89-106, 1926.
157. Kaliner MA. The mast cell-a fascinating riddle. N Engl J Med 301: 498-499, 1979.
158. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
159. Katz HR, Stevens RL, Austen KF. Heterogeneity of mammalian mast cells differentiated in vivo and in vitro. J Allergy Clin Immunol 76: 250-259, 1985.
160. Kawaneimi O, Ferrans VJ, Fulmer JD, Crystal RG. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 40: 717-734, 1979.
161. Keller RT, Roth HP. Hyperchlorhydria and hyperhistaminemia in a patient with systemic mastocytosis. N Engl J Med 283: 1449-1450, 1970.
162. Kelsall MA, Crabb ED. Lymphocytes and Mast Cells. Beiltimore: Williams & Wilkins, pp. 57-59, 1959.
163. Kendall ME, Fields JP, King LE. Cutaneous mastocytosis without clinically obvious skin lesions. J Am Acad Dermatol 10: 903-905, 1984.
164. Kessler DA, Lemger RS, Pless NA, Folkman J. Mast cells and tumor eingiogenesis. Int J Cancer 18: 703-709, 1976.
165. Keyzer JJ, De Monchy JGR, Van Doormaal JJ, Van Voorst Vader PC. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. N Engl J Med 309: 1603-1605, 1983.
166. Kimura A, Tanaka R, Taketomi Y, Dohy H, Fujimura K, Kamada N, Kuramoto A. A case of mastocytoma with leukemia manifestation of its immature form in the terminal stage. Rinsho Ketsueki 20: 1137-1146, 1979.
167. Kirsner JB, Shorter RG. Recent developments in nonspecific inflammatory bowel disease (first of two parts). N Engl J Med 306: 775-785, 1982.
168. Kitamura Y, Yokoyama M, Matsuda H, Ohno T. Spleen colony-forming cell as a common precursor for tissue mast cells and granulocytes. Nature 291: 159-160, 1981.
169. Klatt EC, Lukes RJ, Meyer PR. Benign and malignant mast cell proliferations. Diagnosis and separation using a pH-dependent toluidine blue stain in tissue section. Cancer 51: 1119-1124, 1983.
170. Klaus SN, Winkelmann RK. The clinical spectrum of urticaria pigmentosa. Mayo Clin Proc 40: 923-931, 1965.
171. Klein DC, Raisz LG. Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology 86: 1436-1440, 1970.
172. Kobayasi T, Midtgard K, Asboe-Heuisen G. Ultrastructure of human mast-cell granules. J Ultrastr Res 23: 153-165, 1968.
173. Kootte AMM, Haak A, Roberts LJ. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. Neth J Med 26: 18-20, 1983.
174. Lantis J, Koblenzer PJ. Solitary mast cell tumor. Arch Dermatol 99: 60-63, 1969.
175. Laszlo J. Myeloproliferative disorders (MPD): Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 12: 409-432, 1975.
176. Le Jeunne C, Hugues FC, Rolle G, Jaubert F, Dufat R. Hepatomegaly with portal hypertension indicative of systemic mastocytosis. Rev Med Interne 7: 253-257, 1986.
177. Lennert K. Übersichten: Zur pathologischen Anatomie von Urticaria pigmentosa und Mastzellenreticulose. Klin Wochenschr 40: 61-67, 1962.
178. Lennert K, Schubert JC. Zur Cytochemie der Blutund Gewebsmastzellen. Verh Dtsch Ges Inn Med 66: 1061-1065, 1968.
179. Lennert K, Parwaresch MR. Mast cells and mast cell neoplasia: A review. Histopathology 3: 349-365, 1979.
180. Lewis RA, Roberts LJ H, Holgate ST, Oates JA, Austen KF. Immunologie generation of mast cell prostaglandins and their effects on mast cell cyclic nucleotides. J Allergy Clin Immunol 65: 235, 1980.
181. Lewis RA, Roberts LJ II, Holgate ST, Oates JA, Austen KF. Prostaglandin D2 production by rat and human mast cells activated by reversed anaphylaxis (abstract). Fed Proc 39: 905, 1980.
182. Lewis RA. Mastocytosis. J Allergy Clin Immunol 74: 755-765, 1984.
183. Li C-Y, Travis WD, van Hale PC, Yam LT. Useful cytochemical stains for the diagnosis of systemic mast cell disease (SMCD) (abstract). J Histochem Cytochem 34: 1355, 1986.
184. Liso V, Troccoli G, Specchia G. Mast cell leukemia and acute basophilic leukemia. Bibl Haematol 45: 142-146, 1978.
185. Loesel L. Identification of immunoglobulin E on mast cells in nasal mucosa by the immunoperoxidase technic and counterstained by toluidine blue or alcian blue safranine (letter). Am J Clin Pathol 82: 510, 1984.
186. Ludatscher RM, Haim S, Gellei B, Cohen A. Comparative ultra-structural study of mast cells in mastocytoma and mastocytosis. Dermatologica 155: 80-89, 1977.
187. Marantz C, Roth DG. Systemic mast cell disease, malignant lymphoma, and IgG paraprotein. Milit Med 137: 103-106, 1972.
188. Maseki Y, Miyake Y, Mitsuya H, Kitamura H, Yamada K. Mastocytosis occurring in the testes from patients with idiopathic male infertility. Fertil Steril 36: 814-817, 1981.
189. McCarthy JH, Mandel TE, Garson OM, Metcalfe D. The presence of mast cells in agar cultures. Exp Hematol 8: 562-567, 1980.
190. McDermott WV, Topol BM. Systemic mastocytosis with extensive large cutaneous mastocytomas: Surgical management. J Surg Oncol 30: 221-225, 1985.
191. Meggs WJ, Frieri M, Costello R, Metcalfe DD, Papadopoulos NM. OligoclonaI immunoglobulins in mastocytosis. Ann Intern Med 103: 894-895, 1985.
192. Meggs W, Friedman MM, Kramer N, Metcalfe DD. Lymphadenopathic mastocytosis with eosinophilia (abstract). Clin Res 33: 162A, 1985.
193. Meneghini CL, Angelini G. Systemic mastocytosis with diffuse crocodile-like pachydermic skin, pedunculated pseudofibromas and comedones. Br J Dermatol 102: 329-334, 1980.
194. Metcalfe DD, Kaliner M, Donlon MA. The mast cell. CRC Crit Rev Immunol 2: 23-74, 1981.
195. Metcalfe DD, Kaliner MA. The mast cell and basophil. In: Oppenheim J, Rosenstreich D, Potter M, eds. Cellular Functions in Immunity and Inflammation. New York: Elsevier North Holland, pp. 301-322, 1981.
196. Mihm MC, Clark WH, Reed RJ, Caruso MG. Mast cell infiltrates of the skin and the mastocytosis syndrome. Human Pathol 4: 231-239, 1973.
197. Mikhail GR, Miller-Milinska A. Mast cell population in human skin. J Invest Dermatol 43: 249-254, 1964.
198. Mutter RD, Tannenbaum M, Ultmann JE. Systemic mast cell disease. Ann Intern Med 59: 887-906, 1963.
199. Myers J. Diagnosis: Urticaria pigmentosa. Arch Dermatol 81: 199-200, 1960.
200. Nakahata T, Spicer SS, Cantey JR, Ogawa M. Clonal assay of mouse mast cell colonies in methylcellulose culture. Blood 60: 352-361, 1982.
201. Nakano T, Kanakura Y, Nakahata T, Matsuda H, Kitamura Y. Genetically mast cell-deficient WAVv mice as a tool for studies of differentiation and function of mast cells. Fed Proc 46: 1920-1923, 1987.
202. Naveh Y, Ludatscher R, Gellei B, Haim S, Friedman A. Ultra-structural features of mast cells in systemic mastocytosis. Acta Der-matovener 55: 443-450, 1975.
203. Nettleship: Chronic urticaria, leaving brown stains: Nearly two years duration. Br Med J 2: 323, 1869.
204. Nishioka K, Kobayashi Y, Katayama I, Takijiri C. Mast cell numbers in diffuse scleroderma. Arch Dermatol 123: 205-208, 1987.
205. Nixon RK. The relation of mastocytosis and lymphomatous disease. Ann Intern Med 64: 856-860, 1966.
206. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 49: 2112-2135, 1982.
207. Norrby K. Effect of heparin, histamine and serotonin on the density-dependent inhibition of replication in two fibroblastic cell lines. Virchows Arch [Cell Pathol] 15: 75-93, 1973.
208. Norrby K, Enerback L, Franzen L. Mast cell activation and tissue cell proliferation. Cell Tiss Res 170: 289-303, 1976.
209. Norris HT, Zamcheck N, Gottleib LS. The presence and distribution of mast cells in the human gastrointestinal tract at autopsy. Gastroenterol 44: 448-455, 1963.
210. Olafsson JH. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism. Acta Dermato-venereologica Supplementum 115: 1-43, 1985.
211. Olafsson JH, Roupe G, Enerback L. Dermal mast cells in mastocytosis: Fixation, distribution and quantitation. Acta Derm Venerol (Stockh) 66: 16-22, 1986.
212. O'Laughlin JC, Bredfeldt JE. Treatment of systemic mastocytosis (letter). N Engl J Med 302: 231, 1980.
213. Olsson Y. Mast cells in the nervous system. Int Rev Cytol 24: 27-70, 1968.
214. Orkin M, Good RA, Clawson CC, Fisher I, Windhorst DB. Bullous mastocytosis. Arch Dermatol 101: 547-564, 1970.
215. Ouwendijk RJT, Zijlstra FJ, Wilson JHP, Bontà IL, Vincent JE, Stolz E. Raised plasma levels of thromboxane Ba in systemic mastocytosis. Agents and Actions 13: 514, 1983.
216. Parkin JL, McKenna RW, Brunning RD. Philadelphia chromosome-positive biastic leukemia: Ultrastructural and ultracytochemical evidence of basophil and mast cell differentiation. Br J Haematol 52: 663-677, 1982.
217. Parwaresch MR, Horny H P, Lennert K. Tissue mast cells in health and disease. Path Res Pract 179: 439-461, 1985.
218. Peart KM, Ellis HA. Quantitative observations on the iliac bone marrow mast cells in chronic renal failure. J Clin Pathol 28: 947-955, 1975.
219. Pennacchio L, Mele G. Forma intermedia fra leucemia acuta a promielociti basofili e mastocitosi sistemica. Minerva Medica 62: 3747-3759, 1971.
220. Peterson AH. Systemic mastocytosis: Case report and literature review. J Nat Med Assoc 76: 469-473, 1984.
221. Peto R, Peto J. Asymptotically efficient rank invariant procedures (with discussion). J R Statist Soc (Series A) 135: 185-207, 1972.
222. Pharr PN, Suda T, Bergmann KL, Avila LA, Ogawa M. Analysis of pure and mixed murine mast cell colonies. J Cell Physiol 120: 1-12, 1984.
223. Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN. Neoplastic transformation of mast cells by Abelson-MuLV: Abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41: 685-693, 1985.
224. Pittman DL. Nonspecific staining of mast cells by Avidin-Biotin-Peroxidase Technic (Letter). Am J Clin Pathol 83: 134, 1985.
225. Popa G, Iordacheanu L. Leucemie a mastocytes. Rev Med Chir Soc Med Nat Iasi 81: 519-520, 1977.
226. Poppel MH, Gruber WF, Silber R, Holder AK, Christman RO. The roentgen manifestations of urticaria pigmentosa (mastocytosis). Am J Roentgenol 82: 239-248, 1959.
227. Poynard T, Nataf C, Messing B, Modigliani R. Secretory diarrhea and PGD2 overproduction in systemic mastocytosis. N Engl J Med 299: 186, 1982.
228. Prokocimer M, Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol 75: 34-38, 1981.
229. Rafii M, Firooznia H, Golimbu C, Balthazar E. Pathologic fracture in systemic mastocytosis. Radiographic spectrum and review of the literature. Clin Orthoped Rel Res 180: 260-267, 1983.
230. Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology. Section 3, Fascicle 8. Washington DC: Armed Forces Institute of Pathology, pp 336-344, 1966.
231. Reilly EB, Shintani J, Goodman J. Systemic meist cell disease with urticaria pigmentosa. Arch Dermatol 71: 561-569, 1955.
232. Reisberg IR, Oyakawa S. Mastocytosis with malabsorption, myelofibrosis, and massive ascites. Am J Gastroenterol 82: 54-60, 1987.
233. Remy D. Tissue mast cells and mast cell reticulosis (functional cytology and clinical aspects). Ergebn inn Med Kinderheilk 17: 132-189, 1962.
234. Riccardi VM. Mast cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 123: 1011-1116, 1987.
235. Ridell B, Olafsson JH, Roupe G, Swolin B, Granerus G, Rodjer S, Enerback L. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Arch Dermatol 122: 422-427, 1986.
236. Rider TL, Stein AA, Abbuhl JW. Generalized mast cell disease and urticaria pigmentosa. Report of a case. Pediatrics 19: 1023-1031, 1957.
237. Riley JF. The relationship of the tissue mast cells to the blood vessels in the rat. J Pathol BacterioI 65: 461-469, 1953.
238. Rimmer EF, Turberville C, Horton MA. Human mast cells detected by monoclonal antibodies. J CIin Pathol 37: 1249-1255, 1984.
239. Robbins AH, Schimmel EM, Rao KCVG. Gastrointestinal mastocytosis; radiologic alterations aiter ethanol ingestion. Am J Roentgenol Rad Therapy Nuclear Med 115: 297-299, 1972.
240. Roberts LJ II, Lewis RA, Oates JA, Austen KF. Prostaglandin, thromboxane, and 12-hydroxy-5, 8, 10, 14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta 575: 185-192, 1979.
241. Roberts LJ, Sweetman BJ, Lewis RA, Austen KF, Oates JA. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 303: 1400-1404, 1980.
242. Roberts LJ, Fields JP, Oates JA. Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope. Trans Assoc Am Physicians 95: 36-41, 1982.
243. Roberts LJ, Turk JW, Oates JA. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Adv Shock Research 8: 145-152, 1982.
244. Roberts LJ, Bloomgarden ZT, Marney SR, Rabin D, Oates JA. Histamine release from a gastric carcinoid: Provocation by pentagastrin and inhibition by somatostatin. Gastroenterology 84: 272-275, 1983.
245. Roberts LJ. Recurrent syncope due to systemic mastocytosis. Hypertension 6: 285-294, 1984.
246. Roberts PL, McDonald HB, Wells RF. Systemic mast cell disease in a patient with unusual gastrointestinal and pulmonary abnormalities. Am J Med 45: 638-642, 1968.
247. Robinson HM, Kile RL, Hitch JM, Robinson RCV. Bullous urticaria pigmentosa. Arch Dermatol 85: 346-357, 1962.
248. Roche WR. Mast cells and tumors, the specific enhancement of tumor proliferation in vitro. Am J Pathol 119: 57-64, 1985.
249. Rodenberg JC, Maegaard KK, Svanholm H. Case report 369. Skeletal Radiol 15: 334-337, 1986.
250. Rogers MP, Bloomingdale K, Murawski BJ, Soter NA, Reich P, Austen KF. Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosomatic Med 48: 437-447, 1986.
251. Rohner HG, Bartl R, Koischwitz D, Rodermund OE. Hautund Knochenbefunde bei der Mastocytose. Radiologe 22: 545-552, 1982.
252. Rosenbaum RC, Frieri M, Metcalfe DD. Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis. J Nucl Med 25: 859-864, 1984.
253. Roth JA, Enzinger FM, Tannenbaum M. Synovial sarcoma of the neck: A followup study of 24 cases. Cancer 35: 1243-1253, 1975.
254. Ruitenberg EJ, Gustowska L, Elgersma A, Ruitenberg HM. Effect of fixation on the light microscopical visualization of mast cells in the mucosa and connective tissue of the human duodenum. Int Archs Allergy Appl Immunol 67: 233-238, 1982.
255. Rywlin AM, Hoffman EP, Ortega RS. Eosinophilic fibrohistiocytic lesion of bone marrow: A distinctive new morphologic finding, probably related to drug hypersensitivity. Blood 40: 464-472, 1972.
256. Rywlin AM. Mastocytic eosinophilic fibrohistiocytic lesion of the bone marrow. ASCP Check Sample, Hematology No. H82-H85 (H124), 1982.
257. Sagher F, Cohen C, Schorr S. Concomitant bone changes in urticaria pigmentosa. J Invest Dermatol 18: 425-432, 1952.
258. Sagher F, Liban E, Ungar H, Schorr S. Urticaria pigmentosa with bone involvement. Mast cell aggregates in bones and myelosclerosis found at autopsy in a case dying of monocytic leukemia. J Invest Dermatol 27: 355-368, 1956.
259. Sagher F, Even-Paz Z. Mastocytosis and the Mast Cell. Chicago: Year Book Medical Publishers, 1967.
260. Sangster A. An anomalous mottled rash, accompanied by pruritis, factitious urticaria and pigmentation, "Urticaria pigmentosa?" Trans Clin Soc Lond 11: 161-163, 1878.
261. SAS Institute Inc. SUGI Supplemental Library User's Guide. Version 5 edition. Cary, NC: SAS Institute Inc., pp 662, 1986.
262. Satodate R, Schwarze E-W, Lennert K. Gewebsmastzellenzahl bei Immunocytom und chronischer lymphatischer Leukämie. Virchows Arch [Pathol Anat] 373: 303-309, 1977.
263. Sawers AH, Davson J, Braganza J, Geary CG. Systemic mastocytosis, myelofibrosis and portal hypertension. J Clin Pathol 35: 617-619, 1982.
264. Schrader JW, Crapper RM. Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells. Proc Natl Acad Sci 80: 6892-6896, 1983.
265. Schrader JW. Bone differentiation in vitro. CRC Crit Rev Immunol 4: 196-277, 1983.
266. Schrek R. Cytology of viable blood cells of tissue mast cell leukemia. Two cases. Cancer 19: 134-136, 1966.
267. Schwartz LB, Austen KF. Structure and function of the chemical mediators of mast cells. Prog Allergy 34: 271-321, 1984.
268. Schwartz LB, Metcalfe DD, Miller JS, Earl HE, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316: 1622-1626, 1987.
269. Scott BB, Hardy GJ, Losowsky MS. Involvement of the small intestine in systemic mast cell disease. Gut 16: 918-924, 1975.
270. Scott HW, Parris WCV, Sandidge PC, Oates JA, Roberts LJ O. Hazards in the operative management of patients with systemic mastocytosis. Ann Surg 197: 507-514, 1983.
271. Selye R. The Mast Cells. Washington: Butterworths 1965.
272. Serafín WE, Austen KF. Mediators of immediate hypersensitivity reactions. N Engl J Med 317: 30-34, 1987.
273. Sézary A, Levy-Coblenz G, Chauvillon P. Dermographisme et mastocytose. Bull Soc franc Dermat et Syph 43: 357-359, 1936.
274. Shaw DW, Hocking W, Ahmed AR. Generalized cutaneous mastocytosis and acute myelogenous leukemia. Internat J Derm 22: 109-112, 1983.
275. Simon RA. Treatment of systemic mastocytosis (letter). N Engl J Med 302: 231-232, 1980.
276. Sochocky S. Mastocytosis. Br J Clin Pract 36: 379-382, 1982.
277. Soler J, O'Brien M, Tavares deCastro J, San Miguel JF, Kearney L, Goldman JM, Catovsky D. Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors. Am J Clin Pathol 83: 254-259, 1985.
278. Sostre S, Handler HL. Bony lesions in systemic mastocytosis. Scintigraphic evaluation. Arch Dermatol 113: 1245-1247, 1977.
279. Soter NA, Austen KF. The diversity of mast cell-derived mediators: Implications for acute, subacute, and chronic cutaneous inflammatory disorders. J Invest Dermatol 67: 313-319, 1976.
280. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301: 465-69, 1979.
281. Stanoeva L, Konstantinov D. A case of systemic multinodular mastocytosis. Br J Dermatol 88: 509-511, 1973.
282. Stark E, Van Buskirk FW, Daly JF. Radiologic and pathologic bone changes associated with urticaria pigmentosa. Arch Pathol 62: 143-148, 1956.
283. Stevens RL, Rothenberg ME, Levi-Schaffer F, Austen KF. Ontogeny of in vitro-differentiated mouse mast cells. Fed Proc 46: 1915-1919, 1987.
284. Strobel S, Miller HRP, Ferguson A. Human intestinal mucosal mast cells: Evaluation of fixation and staining techniques. J Clin Pathol 34: 851-858, 1981.
285. Suda J, Suda T, Ogawa M. Analysis of differentiation of mouse hemopoietic stem cells in culture by sequentiell replating of paired progenitors. Blood 64: 393-399, 1984.
286. Sun T, Li C-Y, Yam LT. Atlas of Cytochemistry and Immunochemistry of Hematologic Neoplasms. Chicago: American Society of Clinical Pathologists Press, 1985.
287. Szweda JA, Abraham JP, Fine G, Nixon RK, Rupe CE. Systemic mast cell disease. A review and report of three cases. Am J Med 32: 227-239, 1962.
288. Takeda Y. On the origin of the tissue mast cell. Okajimas Folia Anat Jpn 31: 143-159, 1958.
289. 3H-Thymidine labeled mast cells in mice treated with 20-methylcholanthrene: Proliferation of precursor cells, their transformation into mast cells and migration of the latter. Acta Path Jap 26: 693-702, 1976.
290. Te Velde J, Vismans FJFE, Leenheers-Binnendijk L, Vos CJ, Smeenk D, Bijvoet OLM. The eosinophilic fibrohistiocytic lesion of the bone marrow. A mastocellular lesion in bone disease. Virchows Arch [Pathol Anat] 377: 277-285, 1978.
291. Tharp MD. Southwestern Internal Medicine Conference: The spectrum of mastocytosis. Am J Med Sci 289: 119-32, 1985.
292. Touraine A, Solente G, Renault P. Urticaire pigmentaire avec reaction splénique et myelémique. Bull Soc Franc Dermat et Syph 40: 1691-1694, 1933.
293. Travis WD, Li C-Y, Hoagland HC, Travis LB, Banks PM. Mast cell leukemia: Report of a case and review of the literature. Mayo Clin Proc 61: 957-966, 1986.
294. Travis WD, Li C-Y, Su WPD. Adult-onset urticaria pigmentosa and systemic mast cell disease. Am J Clin Pathol 84: 710-714, 1985.
295. Travis WD, Pierre RV. Preleukemia/dysmyelopoietic syndrome. Lab Med 16: 157-163, 1985.
296. Travis WD, Li C-Y, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 62: 965-972, 1988.
297. Travis WD, Li C-Y Bergstralh EJ. Solid and hematologic malignancies in 60 patients with systemic mast cell disease. Arch Pathol Lab Med, 1988, in press.
298. Travis WD, Li C-Y. Pathology of the lymph node and spleen in systemic mastocytosis. Modem Pathology I: 4-14, 1988.
299. Travis WD, Li C-Y, Balogh K. Systemic mast cell disease: A postmortem study of 12 cases. Proceedings of the American Society of Clinical Pathology Scientific Assembly, Spring Meeting, San Francisco, 1987.
300. Treske von U, Altenahr E, Lindner J. Histomorphologische und cytologische Befunde bei einem Fall von Gewebsmastzell-Retikulose mit akutem leukämieartigem Verlauf. Blut 17: 287-293, 1968.
301. Turk J, Oates JA, Roberts LJ. Intervention with epinephrine in hypotension associated with mastocytosis. J Allergy Clin Immunol 71: 189-192, 1983.
302. Udoji WC, Razavi SA. Mast cells and myelofibrosis. Am J Clin Pathol 63: 203-209, 1975.
303. Ultmann JE, Mutter RD, Tannenbaum M, Warner RRP. Clinical, cytologic, and biochemical studies in systemic mast cell disease. Ann Intern Med 61: 326-333, 1964.
304. Unna PG. Beitrage zur Anatomie und Pathogenese der urticaria simplex und pigmentosa. Mschr prakt Dermat, Dermat Studien 3H: 1, 1887.
305. van Doormaal JJ, Idema IG, de Monchy JGR, Breukelman H, Keyzer JJ, Doorenbos H. Effects of isoprenaline and terbutaline on urinary excretion of histamine and its two main metabolites in systemic mastocytosis. Agents and Actions 18: 269-275, 1986.
306. Vein Kammen E. Generalized mastocytosis. Acta Haematol 52: 129-140, 1974.
307. Vilter RW, Wiltse D. Preleukemia and urticaria pigmentosa followed by acute myelomonoblastic leukemia. Arch Intern Med 145: 349-352, 1985.
308. Volkel N, Kruse H-P. Disodium cromoglycate (Intal) for the symptomatic treatment of generalized mastocytosis. Inn Med 4: 325-330, 1977.
309. von Recklinghausen F. Ueber Eiter-und Bindegwebskorperchen. Virchows Arch [Pathol Anat] 28: 157-197, 1863.
310. Wakem CJ, Bennett JM. Acute mast cell leukemia: cytochemical and clinical features (abstract). Clin Research 18: 687, 1970.
311. Walton S, De Souza EJ. Variation in mast cell numbers in psoriasis and lichen planus: Comparisons with normal skin. Dermatologica 166: 236-239, 1983.
312. Weisserman MA, DuCharme DW, Griffin RL, DeGraaf GL, Robinson FG. Bronchopulmonary and cardiovascular effects of prostaglandin D, in the dog. Prostaglandins 13: 255-269, 1977.
313. Wasserman SI. The meist cell and synovial inflammation. Or, what's a nice cell like you doing in a joint like this? Arthritis Rheum 27: 841-844, 1984.
314. Waters WJ, Lacson PS. Mast cell leukemia presenting as urticeiria pigmentosa. Pediatrics 19: 1033-1042, 1957.
315. Webb TA, Li C-Y, Yam LT. Systemic mast cell disease: A clinical and hematopathologic study of 26 cases. Cancer 49: 927-938, 1982.
316. Weidman Al, Freinks AG. Hodgkin's disease concurrent with urticaria pigmentosa. Arch Dermatol 83: 103-107, 1963.
317. Westin J, Greinerus G, Weinfeld A, Wetterquist H. Histamine metabolism in polycythaemia vera. Scand J Haematol 15: 45-57, 1975.
318. Wick MR, Li C-Y, Pierre RV. Acute nonlymphocytic leukemia with basophilic differentiation. Blood 60: 38-45, 1982.
319. Willemze R, Ruiter DJ, Scheffer E, Van Vloten WA. Diffuse cutaneous mastocytosis with multiple cutaneous mastocytomas. Report of a case with clinical, histopathological and ultrastructural aspects. Br J Dermatol 102: 601-607, 1980.
320. Wingren U, Enerback L. Mucosal mast cells of the rat intestine: A re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. Histochem J 15: 571-582, 1983.
321. Woessner S, Lafuente R, Peirdo P, Roseli R, Rozman C, Sans-Sabreifen J. Systemic mastocytosis: A ceise report. Cytological, cytochemical and ultrastructured considerations. Acta Haematol 58: 321-331, 1977.
322. Wyre HW, Henrichs WD. Systemic mastocytosis and pulmonary eosinophilic greinuloma. JAMA 239: 856-857, 1978.
323. Yam LT, Yam C-F, Li C-Y. Eosinophilia in systemic mastocytosis. Am J Clin Pathol 73: 48-54, 1980.
324. Yeun LT, Chan CH, Li C-Y. Hepatic involvement in systemic mast cell disease. Am J Med 80: 819-26, 1986.
325. Yoo D, Lessin LS, Jensen W. Bone-marrow mast cells in lymphoproliferative disorders. In: Pepys J, Edwards AM, eds. The Mast Cell, Its Role in Health and Disease. Bath, England: Pitman Press, pp 153-158, 1979.
326. Yoo D, Lessin LS, Jensen WN. Bone marrow mast cells in lympho-proliferative disorders. Ann Intern Med 88: 753-757, 1978.
327. Yoo D, Lessin LS. Bone marrow mast cell content in preleukemic syndrome. Am J Med 73: 539-542, 1982.
328. Zak FG, Covey JA, Snodgrass JJ. Osseous lesions in urticaria pigmentosa. N Engl J Med 256: 56-59, 1957.
329. Zucker-Franklin D. Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 56: 534-540, 1980.